Dogwood Therapeutics, Inc. (DWTX) vs Rani Therapeutics Holdings, Inc. (RANI)
A side-by-side comparison of Dogwood Therapeutics, Inc. and Rani Therapeutics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DWTX
Dogwood Therapeutics, Inc.
$1.55HealthcareDelayed quote: Oct 6, 2026, 3:59 PM EDT
RANI
Rani Therapeutics Holdings, Inc.
$0.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — DWTX vs RANI
growth of $100 · dividends reinvested · last 5yDWTX -99.0% (-60.0%/yr)RANI -93.0% (-41.2%/yr)RANI compounded faster over this window
Log scale — wide-divergence pair
DWTX RANI
DWTX vs RANI: by the numbers
- •RANI is the larger company ($54M vs $52M market cap).
- •Both run net losses; DWTX's is the smaller (0.00% vs -618.02% net margin).
Metrics side by side
Valuation
| Metric | DWTX | RANI |
|---|---|---|
| P/S ratio | N/A | 11.10 |
| P/B ratio | 0.76 | 1.38 |
Profitability
| Metric | DWTX | RANI |
|---|---|---|
| Gross margin | 0.00% | 44.89% |
| Operating margin | 0.00% | -2345.99% |
| Net margin | 0.00% | -618.02% |
| ROE | -52.72% | -76.82% |
| ROIC | -38.04% | -63.96% |
Growth (annualized)
| Metric | DWTX | RANI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.95% |
| Total return CAGR (5Y) | -58.44% | -46.70% |
Frequently asked
- How have DWTX and RANI total returns compared?
- Over the past 5 years, DWTX delivered -58.44% and RANI delivered -46.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.